# Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling

> **NCT07641257** · — · NOT_YET_RECRUITING · sponsor: **Ruijin Hospital** · enrollment: 420 (estimated)

## Conditions studied

- Acute Coronary Syndromes (ACS)
- Chronic Coronary Syndrome
- Coronary Artery Disease
- Atherosclerosis Cardiovascular Disease
- Ventricular Remodeling
- Inflammation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07641257
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-30
- **Primary completion:** 2028-05-30
- **Final completion:** 2029-05-30
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641257, "Effects of Icosapent Ethyl on Coronary Plaque, Inflammation, and Ventricular Remodeling". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*